SFDA Approves Registration of ‘Leqembi’ as the First Alzheimer’s Treatment in Saudi Arabia
Riyadh: The Saudi Food and Drug Authority (SFDA) has approved the registration of Leqembi (lecanemab) for the treatment of patients with mild cognitive impairment or mild dementia due to Alzheimer’s disease who carry no copies or only one copy of the …